Furthermore, as observed for other tumor types, pathogenic mutations affecting POLE also seem to be associated with a very high-TMB, defined as hyper-ultra-mutated phenotype in pancreatic cancer [4,54,55]. The gene discussed is POLE; the disease is pancreatic neoplasm.